SignalCorporate
WHO announces start of Ebola vaccine clinical trial in DR Congo
WHO Ebola vaccine clinical trial launch in DR Congo signals public health intervention.
Context
What happened: The WHO announced the first clinical trial of an Ebola vaccine in the outbreak that began in the Democratic Republic of Congo. Participants received the Ervebo vaccine in Bunia, Ituri province.
Key numbers: DRC declared its 17th outbreak in May, with more than 9,700 cases and over 4,600 deaths. The outbreak has been reported in four countries.
Why it matters: The trial will test whether Ervebo offers cross-protection against the Bundibugyo species behind the epidemic. Two Bundibugyo-specific candidates from Oxford and Moderna are expected to join shortly.
What changed
The WHO announced the first clinical trial of an Ebola vaccine in the outbreak that began in the Democratic Republic of Congo. Participants received the Ervebo vaccine in Bunia, Ituri province.
Why it matters
The trial will test whether Ervebo offers cross-protection against the Bundibugyo species behind the epidemic. Two Bundibugyo-specific candidates from Oxford and Moderna are expected to join shortly.